iRadimed (FRA:46K) FFO


FRA:46K iRadimed Corp FRA:46K
87 GF Score
Price €84.50
GF Value €56.02
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is iRadimed FFO?

FFO (Funds from operations) only applies to REITs.

FRA:46K
87GF Score
iRadimed Corp FRA:46K
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is iRadimed (FRA:46K) Overvalued in 2026?

Based on GuruFocus' analysis, iRadimed stock appears to be overvalued. The current stock price of €84.50 is trading 50.8% above its estimated GF Value™ of €56.02. GuruFocus considers iRadimed to be Significantly Overvalued.

Key valuation signals for FRA:46K:

  • FFO:
  • GF Value™: €56.02 vs. price of €84.50 (50.8% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:46K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRadimed Business Description

Other Exchanges IRMD:USA
Address 12705 Ingenuity Drive, Orlando, FL, USA, 32826
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
87GF Score

Get the complete analysis for FRA:46K

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€84.50
Price
€56.02
GF Value